QARNĀ RADIOTHERAPEUTICS
 

Ido brings over 20 years of leadership in immunology, onco-immunology and infectious diseases, having guided four novel therapeutics from initial concept through IND approval and clinical trials. He also pioneered the development of cancer-imaging radiotracers, advancing them from conception to clinical evaluation.

Orit brings over 20 years of expertise in radiochemistry, molecular imaging, and targeted radiotherapeutics, having invented a patented, clinically validated molecular half-life extension platform. A published author of over 100 peer-reviewed papers, she is deeply embedded in the scientific and industry ecosystem with a robust network of collaborators.

Behnaz is a seasoned scientist with roles at the National Cancer Institute (NIH) and as a Faculty Research Associate at Johns Hopkins Medicine, bringing over 10 years of research experience—including two years leading radiotherapy innovation in molecular imaging and targeted therapy.